SELLAS Life Sciences Group (SLS) Research & Development: 2011-2023
Historic Research & Development for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to $5.1 million.
- SELLAS Life Sciences Group's Research & Development fell 12.81% to $5.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $24.0 million, marking a year-over-year increase of 18.45%. This contributed to the annual value of $24.0 million for FY2023, which is 18.45% up from last year.
- Per SELLAS Life Sciences Group's latest filing, its Research & Development stood at $5.1 million for Q4 2023, which was down 12.32% from $5.8 million recorded in Q3 2023.
- In the past 5 years, SELLAS Life Sciences Group's Research & Development ranged from a high of $7.2 million in Q1 2023 and a low of $1.9 million during Q1 2020.
- In the last 3 years, SELLAS Life Sciences Group's Research & Development had a median value of $4.9 million in 2022 and averaged $5.0 million.
- As far as peak fluctuations go, SELLAS Life Sciences Group's Research & Development surged by 129.83% in 2021, and later declined by 12.81% in 2023.
- Quarterly analysis of 4 years shows SELLAS Life Sciences Group's Research & Development stood at $2.8 million in 2020, then increased by 22.45% to $3.4 million in 2021, then surged by 72.30% to $5.8 million in 2022, then fell by 12.81% to $5.1 million in 2023.
- Its Research & Development was $5.1 million in Q4 2023, compared to $5.8 million in Q3 2023 and $5.9 million in Q2 2023.